Equities research analysts expect Cinemark Holdings, Inc. (NYSE:CNK) to post $0.52 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Cinemark’s earnings, with estimates ranging from $0.40 to $0.62. Cinemark reported earnings per share of $0.43 in the same quarter last year, which would indicate a positive year-over-year growth rate of 20.9%. The firm is expected to report its next quarterly earnings results on Friday, November 1st.
On average, analysts expect that Cinemark will report full year earnings of $2.32 per share for the current year, with EPS estimates ranging from $2.22 to $2.39. For the next financial year, analysts anticipate that the company will post earnings of $2.44 per share, with EPS estimates ranging from $2.15 to $2.80. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that follow Cinemark.
Cinemark (NYSE:CNK) last announced its quarterly earnings data on Friday, August 2nd. The company reported $0.86 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.80 by $0.06. The firm had revenue of $957.76 million during the quarter, compared to analysts’ expectations of $906.57 million. Cinemark had a return on equity of 13.75% and a net margin of 6.31%.
Shares of NYSE CNK opened at $36.57 on Friday. The stock has a market capitalization of $4.14 billion, a PE ratio of 19.98, a P/E/G ratio of 1.01 and a beta of 0.69. The company has a debt-to-equity ratio of 2.08, a current ratio of 0.95 and a quick ratio of 0.92. The business has a fifty day moving average price of $37.92 and a two-hundred day moving average price of $38.70. Cinemark has a fifty-two week low of $34.49 and a fifty-two week high of $43.51.
In other news, CFO Sean Gamble sold 5,669 shares of Cinemark stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $41.50, for a total value of $235,263.50. Following the transaction, the chief financial officer now owns 126,025 shares in the company, valued at approximately $5,230,037.50. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 9.00% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of CNK. Mesirow Financial Investment Management Equity Management purchased a new stake in shares of Cinemark during the 2nd quarter valued at about $49,000. Marshall Wace LLP acquired a new stake in Cinemark in the 1st quarter valued at about $65,000. Cerebellum GP LLC acquired a new stake in Cinemark in the 3rd quarter valued at about $118,000. Asset Management One Co. Ltd. grew its stake in Cinemark by 20.0% in the 2nd quarter. Asset Management One Co. Ltd. now owns 4,295 shares of the company’s stock valued at $155,000 after acquiring an additional 716 shares during the last quarter. Finally, Machina Capital S.A.S. grew its stake in Cinemark by 569.4% in the 2nd quarter. Machina Capital S.A.S. now owns 4,686 shares of the company’s stock valued at $169,000 after acquiring an additional 3,986 shares during the last quarter. Institutional investors own 99.86% of the company’s stock.
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of December 31, 2018, it operated 341 theatres and 4,586 screens in 41 states of the United States; and 205 theatres and 1,462 screens in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao, and Paraguay.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.